HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-François Trape Selected Research

Antibodies

11/2017Temporal analysis of IgG antibody responses to Plasmodium falciparum antigens in relation to changing malaria epidemiology in a West African setting.
3/2010Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.
7/2008Antimalarial drug use in general populations of tropical Africa.
11/2007Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
1/2005Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-François Trape Research Topics

Disease

37Malaria
11/2017 - 03/2003
8Infections
06/2014 - 12/2003
4Falciparum Malaria (Plasmodium falciparum Malaria)
10/2017 - 11/2007
3Fever (Fevers)
01/2013 - 07/2008
2Tetanus
01/2016 - 01/2015
2Diphtheria
01/2016 - 01/2015
2Whooping Cough (Pertussis)
01/2016 - 01/2015
1Poliomyelitis (Polio)
01/2016
1Meningitis
02/2012
1Parasitic Diseases (Parasitic Disease)
01/2011
1Bites and Stings (Sting)
11/2010
1Epidemic Louse-Borne Typhus (Typhus)
09/2010
1Spotted Fever Group Rickettsiosis (Rickettsialpox)
09/2010
1Acute malaria
02/2007
1Parasitemia
12/2003

Drug/Important Bio-Agent (IBA)

7AntigensIBA
11/2017 - 12/2003
7Antimalarials (Antimalarial Agents)IBA
01/2015 - 02/2006
6Immunoglobulin G (IgG)IBA
11/2017 - 12/2003
6Pharmaceutical PreparationsIBA
07/2015 - 12/2003
5AntibodiesIBA
11/2017 - 01/2005
5ArtesunateIBA
06/2014 - 02/2006
4VaccinesIBA
01/2016 - 07/2009
4pyrimethamine drug combination fanasil (Fansidar)FDA Link
06/2014 - 12/2004
4Chloroquine (Aralen)FDA LinkGeneric
06/2014 - 12/2004
3InsecticidesIBA
01/2016 - 01/2014
3Merozoite Surface Protein 1 (MSA1)IBA
10/2015 - 01/2005
3artemisinin (artemisinine)IBA
06/2014 - 06/2010
3Quinine (Quinson)FDA Link
06/2014 - 03/2003
2Complex MixturesIBA
10/2017 - 03/2014
2Proteins (Proteins, Gene)FDA Link
01/2015 - 07/2008
2Amodiaquine (Camoquin)FDA Link
06/2014 - 12/2011
2Pyrethrins (Pyrethroids)FDA Link
06/2014 - 12/2011
2Biological ProductsIBA
01/2011 - 02/2009
2Biomarkers (Surrogate Marker)IBA
11/2007 - 12/2003
1Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA
01/2016
1BuffersIBA
07/2015
1Measles VaccineIBA
01/2015
1Pyruvate KinaseIBA
01/2015
1merozoite surface protein 5IBA
01/2014
1Doxycycline (Periostat)FDA LinkGeneric
01/2013
1hemoglobin AAIBA
01/2011
1DNA (Deoxyribonucleic Acid)IBA
09/2010
1N-methylchlorphentermineIBA
06/2010
1ArtemisininsIBA
01/2008
1Malaria VaccinesIBA
11/2007
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2007
1PlacebosIBA
02/2006

Therapy/Procedure

5Therapeutics
06/2014 - 12/2003
4Insecticide-Treated Bednets
09/2015 - 12/2011
2Chemoprevention
01/2015 - 11/2010
1Immunomodulation
02/2009
1Drug Therapy (Chemotherapy)
12/2004